These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19034000)

  • 21. Complement activation by anti-endothelial cell antibodies in MHC-mismatched and MHC-matched heart allograft rejection: anti-MHC-, but not anti non-MHC alloantibodies are effective in complement activation.
    Diujvestijn AM; Derhaag JG; van Breda Vriesman PJ
    Transpl Int; 2000; 13(5):363-71. PubMed ID: 11052273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular mechanisms of allograft rejection.
    Hutchinson IV
    Curr Opin Immunol; 1991 Oct; 3(5):722-8. PubMed ID: 1836731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indirect T cell recognition in allograft rejection.
    Bradley JA
    Int Rev Immunol; 1996; 13(3):245-55. PubMed ID: 8782745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal allograft rejection: investigation of alloantigen presentation by cultured human renal epithelial cells.
    Kirby JA; Ikuta S; Clark K; Proud G; Lennard TW; Taylor RM
    Immunology; 1991 Mar; 72(3):411-7. PubMed ID: 1827426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts.
    Libby P; Tanaka H
    Clin Transplant; 1994 Jun; 8(3 Pt 2):313-8. PubMed ID: 7520306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection.
    Tiriveedhi V; Sarma N; Mohanakumar T
    Int J Immunogenet; 2012 Oct; 39(5):373-80. PubMed ID: 22486939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition.
    Kreisel D; Krupnick AS; Gelman AE; Engels FH; Popma SH; Krasinskas AM; Balsara KR; Szeto WY; Turka LA; Rosengard BR
    Nat Med; 2002 Mar; 8(3):233-9. PubMed ID: 11875493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of kidney-specific peptides and their role in renal allograft rejection.
    Poindexter NJ; Naziruddin B; Oppat W; Flye MW; Mohanakumar T
    Transplant Proc; 1995 Feb; 27(1):900-2. PubMed ID: 7879223
    [No Abstract]   [Full Text] [Related]  

  • 29. Morphologic studies of acute rat cardiac allograft rejection across an isolated major histocompatibility complex class I (RT1A) disparity.
    Forbes RD; Lowry RP; Darden AG; Gomersall M; Marghesco DM
    Transplantation; 1988 May; 45(5):943-8. PubMed ID: 3285541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
    Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
    Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of allogeneic cells on the human T and B cell repertoire.
    van Rood JJ; Claas FH
    Science; 1990 Jun; 248(4961):1388-93. PubMed ID: 1972596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological rejection of grafted tissue in xenogeneic neural transplantation.
    Takei K; Nakano Y; Shinozaki T; Toya S; Tsukada Y; Kohsaka S
    Prog Brain Res; 1990; 82():103-9. PubMed ID: 1705353
    [No Abstract]   [Full Text] [Related]  

  • 34. [Organ transplantation and immune response].
    Ochiai T; Arii S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():632-7. PubMed ID: 15861721
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytomegalovirus induces class II expression in rat heart endothelial cells.
    Ustinov JA; Loginov RJ; Bruggeman CA; van der Meide PH; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(4):644-51. PubMed ID: 8396436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial cell antibodies associated with novel targets and increased rejection.
    Jackson AM; Sigdel TK; Delville M; Hsieh SC; Dai H; Bagnasco S; Montgomery RA; Sarwal MM
    J Am Soc Nephrol; 2015 May; 26(5):1161-71. PubMed ID: 25381426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloantigen processing and presentation.
    Tambur AR; Gebel HM
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1031-7. PubMed ID: 8719446
    [No Abstract]   [Full Text] [Related]  

  • 38. [HLA mismatch and graft rejection].
    Matsuyoshi H; Senju S; Monji M; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():621-31. PubMed ID: 15861720
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells.
    Waldman WJ; Knight DA; Adams PW; Orosz CG; Sedmak DD
    Transplantation; 1993 Dec; 56(6):1504-12. PubMed ID: 7904091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rendezvous before rejection: where do T cells meet transplant antigens?
    Briscoe DM; Sayegh MH
    Nat Med; 2002 Mar; 8(3):220-2. PubMed ID: 11875489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.